Phyton Biotech to Showcase Specialty Fermentation at CPhI Worldwide This November
This November, Phyton Biotech will be at stand 121A50 at CPhI Worldwide 2022 in Frankfurt.
This November, Phyton Biotech will be at stand 121A50 at CPhI Worldwide 2022 in Frankfurt.
Dr. Marisol Ochoa-Villareal joins Phyton Biotech's R&D Team in Germany.
Phyton Biotech is pleased to announce organizational changes at Phyton Biotech in Germany.
Phyton Biotech will showcase its specialty fermentation solutions at CPhI Worldwide online and in-person, this October and November.
Phyton Biotech will showcase its specialty fermentation solutions at CPhI Worldwide online and in-person, this October and November.
Phyton Biotech is pleased to announce approval from China’s regulatory body – National Medical Products Administration (NMPA) - for Phyton’s Drug Master File for paclitaxel active pharmaceutical ingredient produced via plant cell fermentation (PCF®).
Phyton Biotech’s Plant Cell Fermentation (PCF) technology has been successfully used to develop high-yielding plant cell lines of the source of cyclopamine, a key raw material for PellePharm’s patedigib topical gel.
Phyton Biotech is committed to the health and safety of our employees first, and minimizing any interruptions so we can reliably supply our Active Pharmaceutical Ingredients.
Phyton Biotech’s Vice-President, Sales & Marketing, Jackie Labbe was delighted to speak with SpeakPharma recently about Phyton Biotech.
Watch the video now to learn more about Plant Cell Fermentation Technology®